Avalon GloboCare Corp. Files 8-K Report
Ticker: ALBT · Form: 8-K · Filed: Oct 25, 2024 · CIK: 1630212
Sentiment: neutral
Topics: sec-filing, 8-k, disclosure
TL;DR
Avalon GloboCare filed an 8-K, likely containing financial updates or regulatory disclosures.
AI Summary
On October 25, 2024, Avalon GloboCare Corp. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt.
Why It Matters
This filing indicates that Avalon GloboCare Corp. is providing updates or disclosures to the SEC, which could contain important information for investors regarding the company's financial status or regulatory compliance.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing notification and does not contain specific financial performance data or significant corporate events that would indicate high risk.
Key Players & Entities
- Avalon GloboCare Corp. (company) — Registrant
- 0001630212 (company) — Central Index Key
- 471685128 (company) — IRS Number
- DE (company) — State of Incorporation
- NJ (company) — State of Business Address
- 07728 (company) — ZIP Code of Business Address
- 732-780-4400 (company) — Business Phone Number
FAQ
What is the primary purpose of this 8-K filing by Avalon GloboCare Corp.?
The filing is for Regulation FD Disclosure and Financial Statements and Exhibits, as indicated by the 'ITEM INFORMATION' section.
When was this 8-K report filed?
The report was filed as of October 25, 2024.
What is Avalon GloboCare Corp.'s state of incorporation?
Avalon GloboCare Corp. is incorporated in Delaware (DE).
What is the principal executive office address for Avalon GloboCare Corp.?
The address is 4400 Route 9 South, Suite 3100, Freehold, NJ 07728.
What is the SIC code for Avalon GloboCare Corp.?
The Standard Industrial Classification (SIC) code is 2836, for BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
Filing Stats: 570 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2024-10-25 09:00:07
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share ALBT The Nasdaq Capital M
Filing Documents
- ea0218632-8k_avalon.htm (8-K) — 32KB
- ea021863201ex99-1_avalon.htm (EX-99.1) — 10KB
- ex99-1_001.jpg (GRAPHIC) — 10KB
- 0001213900-24-090541.txt ( ) — 230KB
- albt-20241025.xsd (EX-101.SCH) — 3KB
- albt-20241025_lab.xml (EX-101.LAB) — 33KB
- albt-20241025_pre.xml (EX-101.PRE) — 22KB
- ea0218632-8k_avalon_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AVALON GLOBOCARE CORP. Dated: October 25, 2024 By: /s/ Luisa Ingargiola Name: Luisa Ingargiola Title: Chief Financial Officer 2